Возможности оценки экспрессии маммаглобина при различной патологии молочной железы. Литературный обзор

Автор: Боженко В.К., Васкевич Е.Ф., Кудинова Е.А., Чазова Н.Л., Берщанская А.М., Мельникова Н.В., Тащян А.А., Слонов А.В.

Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr

Рубрика: Обзоры

Статья в выпуске: 1 т.10, 2010 года.

Бесплатный доступ

В работе проанализированы возможности оценки экспрессии мРНК и белка маммаглобина при раке молочной железы.

Маммаглобин, рак молочной железы, экспрессия мрнк маммаглобина, иммуногистохимическое исследование

Короткий адрес: https://sciup.org/14955192

IDR: 14955192

Список литературы Возможности оценки экспрессии маммаглобина при различной патологии молочной железы. Литературный обзор

  • Высоцкая И.В. Современные возможности терапии фиброзно-кистозной болезни.//Опухоли женской репродуктивной системы. 2009 N1-2с.44-46
  • Давыдов М. И., Аксель Е. М. Смертность населения России и стран СНГ от злокачественных образований в 2006 г.//Вестник РОНЦ им. Н. Н. Блохина РАМН, т. 19, №2 (прил. 1), 2008 с.91-119
  • Харченко В.П., Рожкова Н.И., Меских Е.В. «Скрининг и возможности совершенствования ранней диагностики рака молочной железы», доклад.//Вестник Московского Онкологического Общества, №11, ноябрь 2006
  • Becker R.M., Darrow C., Zimonjic D.B., Popescu N.C., Watson M.A., Fleming T.P. Identification of mammaglobin B, a novel member of the uteroglobin gene family.//Genomics 1998; 54:70-78.
  • Bernstein J.L., Godbold J.H., Raptis G, et al. Identification of mammaglobin as a novel serum marker for breast cancer.//Clinical Cancer Research 2005;11:6528-35.
  • Bhargava R., Beriwal S., Dabbs D.J. Mammaglobin vs GCDFP-15 An Immunohistologic Validation Survey for Sensitivity and Specificity.//Am. J. Clinical Pathology. 2007 v.127 p.103-113.
  • Bustin S.A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems//J. Molecular Endocrinology, 2002,29:23-39
  • Bustin S.A., Dorudi S. Molecular assessment of tumor stage and disease recurrrnce using PCR-based assays//Molecular Med. Today., 1998, 4:389-396
  • Cerveira N, Torres L, Rocha P, Bizarro S, Pereira D, Abreu J, Henrique R, Teixeira MR, Castedo S. Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients. Int J Cancer. 2004 Feb 10;108(4):592-5
  • Desiardin L.E., Perkins M.D.,Wolski K., Haun S. and all, Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for responds to chemothera py//Am J Respir Crit Care Med., 1999, 160: 203-210.
  • Fairman J., Riche L., Pieslak I., Lay M., Corson S., Fox E. at all. Quantitative RT-PCR to evaluate in vivo expression of multiple transgenes using a common intron//Biotechniques, 1999, 27:566-570, 572-574
  • Fanger G.R., Houghton R.L., Retter M.W., Hendrickson R.C., Babcook J., Dillon D.C., Durham M.D, Reynolds L.D., Johnson J.C., Carter D., Fleming T.P., Roche P.C., Persing D.H., Reed S.G. Detection of mammaglobin in the sera of patients with breast cancer.//Tumour Biol. 2002 Jul-Aug;23(4):212-21
  • Ghossein A., Rosai J., Polymerase chain reaction in the detection of micrometastases and circulating tumor cells.//Cancer, 1996, 78:10-16
  • Grunewald K, Haun M, Fiegl M, Urbanek M, Muller-Holzner E, Massoner A, Riha K, Propst A, Marth C, Gastl G. Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction.//Lab Invest. 2002;82:1147-1153
  • Grünewald K, Haun M, Urbanek M, Fiegl M, Müller-Holzner E, Gunsilius E, Dünser M, Marth C, Gastl G: Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19.//Lab Invest 2000, 80:1071-1077.
  • Higuchi R. Kinetic PCR Analysis: Real-time monitoring of DNA amplification reactions//Biotechnology.-1993.-№ 11.-1026-1030.
  • Kopreski M.S., Benko F.A., Kwak L.W., Gocke C.D. Detection of tumor messenger RNA in serum of patients with malignant melanoma.//Clinical Cancer Research 1999, 5:1961-1965
  • Leygue E., Snell L., Dotzlaw H., et al. Mammaglobin, a potential marker of breast cancer nodal metastasis.//J Pathology 1999;189:28-33
  • Lin Y.C., Chow-Wu Y.H., Liao С., Cheng A.J. The expression of mammaglobin mRNA in peripheral blood of metastatic breast cancer patients as an adjunct to serum tumor markers.//Cancer Letters 2003 v.191, №1 p.93-99
  • Marques A.R., Teixeira E., Diamond J., Correia H., Santos S., Neto L., Ribeiro M., Miranda A., Passos-Coelho J.L. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.//Breast Cancer Res. Treat. 2009 v.114 №2 p.223-32
  • Min CJ, Tafra L, Verbanac KM. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes.//Cancer Research. 1998; 58: 4581-4.
  • Mikhitarian K, Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study.//BMC Cancer.2008 Feb 20;8 (1):55
  • Mitas M, Mikhitarian K, Walters C, et al. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel.//Int J Cancer 2001;93:162-71.
  • Muller-Schottle F., Classen-Linke I., Beier-Hellwig K., Sterzik K., Beier H.M. Uteroglobin expression and release in the human endometrium.//Ann. NY Acad. Sci. 2000; 923 p.332-335.
  • Nunez-Villar M.J., Martinez-Arribas F., Pollan M. et al. Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype.//Breast Cancer Resуфкср. 2003 v.5 p.R65-R70
  • O'Brien N.A., Teresa M. Maguire, Norma O'Donovan4, Niamh Lynch et al. Mammaglobin A: A Promising Marker for Breast Cancer.//Clinical Chemistry 48: 1362-1364, 2002;
  • Okami J, Dohno K, Sakon M, Iwao K, Yamada T, Yamamoto H, Fujiwara Y, Nagano H, Umeshita K, Matsuura N, Nakamori S, Monden M. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.//Clinical Cancer Research. 2000; v.6 p.2326-2332.
  • Ouellette R.J., Richard D., Maïcas E. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes. Am J Clin Pathol. 2004 v.121p.637-643
  • Raica M., Cîmpean A.M., Meche A., Alexa A., Suciu C., Mureşan A. Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis. Rom. J. Morphol. Embryology. 2009 v.50 №3 p.341-7.
  • Ramachandran C.,Melnick S.J. Multidrug resistance in human tumors-molecular diagnosis and clinical significance.//Mol Diagn., 1999, 4:81-94
  • Roncella S, Ferro P, Bacigalupo B, Dessanti P, Giannico A at all. Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors.//J.Exp Clin Cancer Res. 2006 Mar; 25(1):65-72.
  • Sasaki E., Tsunoda N., Hatanaka Y., Mori N., Iwata H., Yatabe Y. Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers.//Mod. Pathol. 2007 v.20 №2 p.208-14
  • Sjodin A, Guo D, Hofer PA, Henriksson R, Hedman H. Mammaglobin in normal human sweat glands and human sweat gland tumors.//J Invest Dermatol. 2003;121:428-429
  • Sjodin A, Guo D, Sorhaug S, Bjermer L, Henriksson R, Hedman H. Dysregulated secretoglobin expression in human lung cancers.//Lung Cancer. 2003; 41:49-56.
  • Sjodin A., Guo D., Lund-Johansen M., Krossnes B.K., Lilleng P., Henriksson R., Hedman H. Secretoglobins in the human pituitary: high expression of lipophilin B and its down-regulation in pituitary adenomas.//Acta Neuropathol (Berl). 2005 v.109 p.381-386
  • Span P.N., Grebenchtchikov N.I., Geurts-Moespot A., Sweep С. G. J. Concerns about mammaglobin assays.//Clinical Chemistry 2005 v.51 №2 р.474-75
  • Span P.N., Waanders E., Manders P. et al. Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.//J. Clinical Oncology. 2004 v.22 p.691-698
  • Stoeckelhuber M., Messmer E.M., Schmidt C., Xiao F., Schubert C., Klug J. Immunohistochemical analysis of secretoglobin SCGB 2A1 expression in human ocular glands and tissues.//Histochem Cell Biology. 2006; v.126 p.103-109.
  • Suchy B, Austrup F, Driesel G, et al: Detection of mammaglobin expressing cells in blood of breast cancer patients.//Cancer Letters 158:171-178, 2000
  • Takeda Y., Tsuta K., Shibuki Y., Hoshino T., Tochigi N., Maeshima A.M., Asamura H., Sasajima Y., Ito T http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Ito%20T%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus ., Matsuno Y. Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. // Arch. Pathol. Lab. Med. 2008 v.132 №2 p.239-43
  • Tassi R.A., Calza S., Ravaggi A., Bignotti E., Odicino F.E. Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.//BMC Cancer. 2009 v.9 p.253
  • Viale G http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Viale%20G%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus ., Dell'Orto P http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dell'Orto%20P%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus ., Biasi M.O http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Biasi%20MO%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus ., Stufano V http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Stufano%20V%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus ., De Brito Lima L.N http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22De%20Brito%20Lima%20LN%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus ., Paganelli G http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Paganelli%20G%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus ., Maisonneuve P http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Maisonneuve%20P%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus ., Vargo J.M http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Vargo%20JM%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus ., Green G http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Green%20G%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus ., Cao W http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Cao%20W%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus ., Swijter A http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Swijter%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus ., Mazzarol G http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Mazzarol%20G%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus . Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients //Ann. Surg. javascript:AL_get(this,%20'jour',%20'Ann%20Surg.'); 2008 v. 247 №1 p.136-42
  • Wang Z., Spaulding B., Sienko A., Liang Y., Li H., Nielsen G.,. Gong G. Y, Ro J. Y., Zha Q.J. Mammaglobin, a valuable diagnostic marker for metastatic breast сarcinoma//Int. J. Clin. Exp. Pathol. 2009 v.2 №4 p.384-389.
  • Watson M.A., Dintzis S., Darrow C.M., Voss L.E., DiPersio J., Jensen R., Fleming T.P.: Mammaglobin expression in primary, metastatic, and occult breast cancer.//Cancer Research 1999, 59: 3028-3031.
  • Watson M.A., Fleming T.P. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer.//Cancer Research 1996;56:860-865
  • Wong S.C., Lo S.F., Cheung M.T. at all.: Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients.//Clinical Cancer Research 2004, 10:1613-1617
  • X-F Guan, Mohammad K. Hamedani,1 Adewale Adeyinka, Christina Walker, Angela Kemp, Leigh C. Murphy, Peter H. Watson, and Etienne Leygue Relationship between mammaglobin expression and estrogen receptor status in breast tumors.//Endocrine, vol. 21, no. 3, 245-250, August 2003
  • Xiao F., Mirwald A., Papaioannou M., Baniahmad A., Klug J. Secretoglobin 2A1 is under selective androgen control mediated by a peculiar binding site for Sp family transcription factors.//Mol. Endocrinol. 2005 v.19 p.2964-2978
  • Zehentner B.K., Persing D.H., Deme A., Toure P., Hawes S.E., Brooks L., Feng Q., Hayes D.C., Critichlow C.W., Houghton R.L., Kiviat N.B. Expression of Mammaglobin, B305D, GABAπ and B726P and elevation of mammaglobin protein in the peripheral blood of women with untreated breast cancers.//Clinical Chemistry. 2004 November; 50(11): 2069-2076.
  • Zuo L., Li L., Wang Q., Fleming T. P., You S. Mammaglobin as a potential molecular target for breast cancer drug delivery.//Cancer Cell Int. 2009 v.9 p.8.
Еще
Статья обзорная